雌激素及其受体在克罗恩病发生和发展中作用的研究进展

doi:10.16352/j.issn.1001-6325.2022.03.017

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (3): 494-497.doi: 10.16352/j.issn.1001-6325.2022.03.017

雌激素及其受体在克罗恩病发生和发展中作用的研究进展

武国智^1,2, 安丽娜^1,2, 刘敏^1,2, 王玉平^1,2, 郭庆红^1,2*

1.兰州大学第一临床医学院,甘肃兰州 730000;
2.兰州大学第一医院消化科甘肃省胃肠病重点实验室,甘肃兰州 730000

收稿日期:2020-10-22 修回日期:2021-04-06 出版日期:2022-03-05 发布日期:2022-03-04
通讯作者: ^* guoza@sohu.com
基金资助:
国家重点研发计划(2016YFC0107006);国家自然科学基金(81960430);甘肃省自然科学基金(21JR1RA117);兰州大学第一医院院内基金(ldyyyn2018-38);

Research progress on estrogen and its receptors in occurrence and advance of Crohn's disease

WU Guo-zhi^1,2, AN Li-na^1,2, LIU Min^1,2, WANG Yu-ping^1,2, GUO Qing-hong^1,2*

1. The First Clinical Medical College, Lanzhou University, Lanzhou 730000;
2. Department of Gastroenterology, Key Laboratory of Gastrointestinal Diseases of Gansu Province, the First Hospital of Lanzhou University,Lanzhou 730000, China

Received:2020-10-22 Revised:2021-04-06 Online:2022-03-05 Published:2022-03-04
Contact: ^* guoza@sohu.com

摘要/Abstract

摘要： 克罗恩病(CD)的发生与内分泌系统的调节紊乱相关,其中雌激素及其受体的失调在CD的发病机制中扮演着重要的作用。研究发现雌激素可以下调相关炎性因子的表达,适当地补充雌激素有助于减轻炎性反应程度。而其受体(GPER、ERα和ERβ)表达也在局部免疫反应方面起作用,三者表达水平的失调介导肠道炎性反应的发生。结合目前的研究来看,雌激素及其受体有望成为研究CD发生发展的新方向。

关键词: 克罗恩病, 炎性肠病, 雌激素, 受体, 机制

Abstract: Crohn's disease (CD) is a subtype of inflammatory bowel diseases and may be resulted from endocrine disorders. Estrogen and its receptors exert an important role in the pathogenesis of CD. Studies have revealed that estrogen can down-regulate the expression of inflammatory mediators while estrogen supplementation helps reduce the severity of inflammatory response. The expression of receptors (GPER, ERα and ERβ) also influence local immune responses, and the imbalance of them mediate intestinal inflammation. Nowadays, estrogen and its receptors are expected to become a new rarget in the research of CD.

Key words: Crohn's disease, inflammatory bowel disease, estrogen, receptor, mechanism

中图分类号:

R574

武国智, 安丽娜, 刘敏, 王玉平, 郭庆红. 雌激素及其受体在克罗恩病发生和发展中作用的研究进展[J]. 基础医学与临床, 2022, 42(3): 494-497.

WU Guo-zhi, AN Li-na, LIU Min, WANG Yu-ping, GUO Qing-hong. Research progress on estrogen and its receptors in occurrence and advance of Crohn's disease[J]. Basic & Clinical Medicine, 2022, 42(3): 494-497.

参考文献

[1]Mao R, Kurada S, Gordon I, et al. The mesenteric fat and intestinal muscle interface: creeping fat influencing stricture formation in Crohn's disease[J]. Inflamm Bowel Dis, 2019, 25: 421-426.
[2]Thomann A, Reindl W, Wüstenberg T, et al. Aberrant brain structural large-scale connectome in Crohn's disease[J]. Neurogastroenterol Motil, 2019, 31. doi: 10.1111/nmo.13593.
[3]关玉霞, 尤丽丽, 王田田, 等. 炎性肠病患者知觉压力和应对方式与抑郁水平的相关性[J]. 基础医学与临床, 2019, 39: 1623-1626.
[4]陈丹, 李骥, 张鑫垚, 等. 克罗恩病患者维生素D水平与细胞因子的相关性研究[J]. 中华医学杂志, 2020,100: 757-762.
[5]Shah SC, Khalili H, Gower-Rousseau C, et al. Sex-based differences in incidence of inflammatory bowel diseases-pooled analysis of population-based studies from western countries[J]. Gastroenterology, 2018, 155: 1079-1089.
[6]Shah SC, Khalili H, Chen CY, et al. Sex-based differ-ences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region[J]. Aliment Pharmacol Ther, 2019, 49: 904-911.
[7]Kravdal O, Magnus P, Moum B, et al. Association of childbearing with a short-term reduced risk of Crohn disease in mothers[J]. Am J Epidemiol, 2020, 189: 294-304.
[8]Cook LC, Hillhouse AE, Myles MH, et al. The role of estrogen signaling in a mouse model of inflammatory bowel disease: a helicobacter hepaticus model[J]. PLoS One, 2014, 9. Doi: 10.1371/journal.pone.0094209.
[9]Jacenik D, Zielińska M, Michlewska S, et al. Visualiza-tion of estrogen receptors in colons of mice with tnbs-induced Crohn's disease using immunofluorescence[J]. J Vis Exp, 2020. doi: 10.3791/60813.
[10]Van der Giessen J, Van der Woude CJ, Peppelenbosch MP, et al. A direct effect of sex hormones on epithelial barrier function in inflammatory bowel disease models[J]. Cells, 2019, 8: 261-273.
[11]Liu JM, Yu CP, Chuang HC, et al. Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases[J]. Prostate Cancer Prostatic Dis, 2019, 22: 475-482.
[12]Lahat A, Falach-Malik A, Haj O, et al. Change in bowel habits during menstruation: are IBD patients different?[J]. Therap Adv Gastroenterol, 2020, 13. doi: 10.1177/1756284820929806.
[13]Rolston VS, Boroujerdi L, Long MD, et al. The influence of hormonal fluctuation on inflammatory bowel disease symptom severity-a cross-sectional cohort study[J]. Inflamm Bowel Dis, 2018, 24: 387-393.
[14]Lachowski D, Cortes E, Matellan C, et al. G protein-coupled estrogen receptor regulates actin cytoskeleton dynamics to impair cell polarization[J]. Front Cell Dev Biol, 2020, 8. doi: 10.3389/fcell.2020.592628.
[15]Liu J, Lin G, Fang M, et al. Localization of estrogen receptor ERα, ERβ and GPR30 on myenteric neurons of the gastrointestinal tract and their role in motility[J]. Gen Comp Endocrinol, 2019, 272: 63-75.
[16]Jacenik D, Cygankiewicz AI, Mokrowiecka A, et al. Sex- and age-related estrogen signaling alteration in inflammatory bowel diseases: modulatory role of estrogen receptors[J]. Int J Mol Sci, 2019, 20. doi: 10.3390/ijms20133175.
[17]Linares P, Algaba A, Urzainqui A, et al. Ratio of circulating estrogen receptors beta and alpha (ERβ/ERα) indicates endoscopic activity in patients with Crohn's disease[J]. Dig Dis Sci, 2017, 62: 2744-2754.
[18]Jacenik D, Cygankiewicz AI, Fichna J, et al. Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome[J]. Mol Cell Endocrinol, 2018, 471: 89-96.
[19]Zimmerman MA, Ogola BO, Wilkinson MM, et al. Medroxyprogesterone opposes estradiol-induced renal damage in midlife ovariectomized long evans rats[J]. Menopause, 2020, 27: 1411-1419.
[20]Pelekanou V, Kampa M, Kiagiadaki F, et al. Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1[J]. J Leukoc Biol, 2016, 99: 333-347.
[21]Cabas I, Rodenas M, Abellán E, et al. Estrogen signal-ing through the G protein-coupled estrogen receptor regulates granulocyte activation in fish[J]. J Immunol, 2013, 191: 4628-4639.
[22]Xiao L, Luo Y, Tai R, et al. Estrogen receptor β suppresses inflammation and the progression of prostate cancer[J]. Mol Med Rep, 2019, 19: 3555-3563.
[23]Goodman W, Bedoyan S, Havran H, et al. Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine[J]. Proc Natl Acad Sci U S A, 2020, 117: 17166-17176.
[24]Goodman W, Havran H, Quereshy H, et al. Estrogen receptor α loss-of-function protects female mice from dss-induced experimental colitis[J]. Cell Mol Gastroenterol Hepatol, 2018, 5: 630-633.
[25]Braniste V, Leveque M, Buisson-Brenac C, et al. Oestradiol decreases colonic permeability through oestrogen receptor beta-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells[J]. J Physiol, 2009, 587: 3317-3328.
[26]Li HX, Chen H, Chen L, et al. Expression of oestrogen receptor beta was negatively correlated with disease activity in patients with Crohn's disease involving the terminal ileum[J]. Steroids, 2019,141: 36-40.

雌激素及其受体在克罗恩病发生和发展中作用的研究进展

Research progress on estrogen and its receptors in occurrence and advance of Crohn's disease

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	林柏柏, 钱风华, 钱义明, 赵雷, 孙旗, 褚梦瑶, 沈梦雯. 脓毒症并发毛细血管渗漏综合征的研究进展[J]. 基础医学与临床, 2022, 42(7): 1144-1147.
[2]	赵肖灵, 何润之, 孙玉姣, 张小冲, 杨林芳, 王瑞, 程芳. 活动期白癜风患者血清γ干扰素含量升高[J]. 基础医学与临床, 2022, 42(7): 1067-1070.
[3]	孙健茹, 仇文颖, 钱晓菁, 马超. Fc-gamma Ⅰ型受体在阿尔茨海默病患者和模型小鼠脑皮质的表达[J]. 基础医学与临床, 2022, 42(5): 740-744.
[4]	戴靖榕, 李婕, 何旭, 李燕. 评估老年衰弱相关血清生物学标志物的研究进展[J]. 基础医学与临床, 2022, 42(4): 646-650.
[5]	李蓉, 朱含月. 酮咯酸氨丁三醇抑制膝骨关节炎模型大鼠炎性反应[J]. 基础医学与临床, 2022, 42(3): 417-422.
[6]	刘峰宇, 韩薇. 心肌细胞钙稳态失调在心力衰竭中作用的研究进展[J]. 基础医学与临床, 2022, 42(3): 502-506.
[7]	杨溢铎, 国海东, 邵水金, 刘玉璞. 雪旺细胞促进周围神经再生机制的研究进展[J]. 基础医学与临床, 2022, 42(1): 145-148.
[8]	张杨孙弯弯陆丽丹冯晓玲. 细胞自噬与凋亡相互作用分子机制的研究进展[J]. 基础医学与临床, 2021, 41(9): 1342-1346.
[9]	薛奋勤李华刘丽娜许晴薛冰魏华. 用电压钳检测烟碱型乙酰胆碱受体导电孔道的重要位点[J]. 基础医学与临床, 2021, 41(9): 1309-1312.
[10]	韦碧薇龚雅慧苏州杨慧莹覃蒙斌梁志海. miR-125b参与TRAF6影响的人胰腺导管上皮屏障作用[J]. 基础医学与临床, 2021, 41(9): 1272-1276.
[11]	王行行王导新. NETs与急性呼吸窘迫综合征的研究进展[J]. 基础医学与临床, 2021, 41(7): 1047-1051.
[12]	焦瑒贾颖朱苹张倩马晓丽. 尼古丁成瘾机制的研究进展[J]. 基础医学与临床, 2021, 41(7): 1060-1065.
[13]	郭希赖莘秀杨媚滟李峤桢王思行宋章永. 抑制侵袭性真菌的新型分子及其作用靶点研究进展[J]. 基础医学与临床, 2021, 41(6): 904-908.
[14]	赵平平刘靖芳. 假性甲状旁腺功能减退症的临床特点和分子遗传学机制研究进展[J]. 基础医学与临床, 2021, 41(4): 584-588.
[15]	郑亚男李梅赵基源. 乳腺癌骨转移分子机制及靶向药物的研究进展[J]. 基础医学与临床, 2021, 41(3): 433-437.